News Sentiment

BOLD sentiment intelligence

Boundless Bio, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.41 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 55

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend active

-3.6% over one week, +70.9% over four weeks, trend active, and near fair-value range.

Latest direct headline Positive

63,969 shares bought by Tang Capital in Boundless Bio, Inc. (BOLD)

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -3.6% Price reacting lower
Trend fit Trend active 70.9% over four weeks
Fair value -13.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 22
Neutral 36
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 55
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 9
Market source 6
TradingView 6
Investing.com 4
Investing.com South Africa 3
Finbold 2
Stocktwits 2
Investing.com Nigeria 2

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 19
Deals and strategy 10
Analyst action 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 63
Stock Titan Direct company coverage

Tang Capital-affiliated funds boost Boundless Bio (BOLD) stake with 286K-share buy

Funds affiliated with Tang Capital increased their stake in Boundless Bio (BOLD) by purchasing 286,333 shares between June 25-29, 2026. These open-market purchases were made at weighted-average prices generally ranging from $2.40 to $2.60 per share, through various Tang Capital l

Tone
Positive 70/100
Event
Deals and strategy
Published
30 Jun 2026 00:10
Source
Stock Titan
Investing.com South Africa Direct company coverage

Tang Capital Management acquires $714,768 of Boundless Bio stock By Investing.com

Tang Capital Management LLC, led by Kevin Tang, recently acquired 286,333 shares of Boundless Bio (NASDAQ: BOLD) common stock for $714,768 through multiple transactions between June 25 and June 29, 2026. These purchases were made at prices ranging from $2.47 to $2.56 per share, i

Tone
Positive 64/100
Event
Market update
Published
30 Jun 2026 00:10
Source
Investing.com South Africa
Stock Titan Direct company coverage

Tang-linked entities report 11.3% stake in Boundless Bio (NASDAQ: BOLD)

A Schedule 13G filing reveals that Tang Capital Management, Kevin Tang, and affiliated entities collectively beneficially own 11.3% of Boundless Bio (NASDAQ: BOLD), representing 2,533,845 shares. This passive investment indicates shared voting and dispositive power among the invo

Tone
Neutral 50/100
Event
Deals and strategy
Published
30 Jun 2026 00:10
Source
Stock Titan
Investing.com South Africa Direct company coverage

Form 4 Boundless Bio Inc For: 29 June By Investing.com

This article from Investing.com reports the filing of a Form 4 for Boundless Bio Inc. dated June 29. It provides no further details beyond the title and a stock symbol (BOLD) with a slight price drop. The content primarily consists of market data and unrelated news headlines.

Tone
Negative 42/100
Event
Market update
Published
30 Jun 2026 00:10
Source
Investing.com South Africa
TradingView Direct company coverage

Enterprise value to revenue forward of Boundless Bio, Inc. – NASDAQ:BOLD

The article provides financial information for Boundless Bio, Inc. (NASDAQ: BOLD), specifically focusing on its enterprise value to revenue forward metric. It appears to be a financial data page from TradingView, offering an overview of the company's financials, news, and technic

Tone
Neutral 50/100
Event
Earnings
Published
29 Jun 2026 17:10
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Boundless Bio, Inc. – NASDAQ:BOLD

This article provides the forward price-to-sales ratio for Boundless Bio, Inc. (NASDAQ: BOLD), as listed on TradingView. It indicates that the NASDAQ market was closed at the time the data was presented, with no trades reported. The content is primarily a data point surrounded by

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 06:41
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Boundless Bio, Inc. – NASDAQ:BOLD

This article focuses on the enterprise value to EBITDA forward for Boundless Bio, Inc. (NASDAQ: BOLD). It appears to be a placeholder or a stub page from TradingView, indicating financial data for the company. The page structure suggests it's part of a larger financial data servi

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 13:39
Source
TradingView
www.marketscreener.com Direct company coverage

Serapha Bio, Inc. entered into a definitive merger agreement to acquire Boundless Bio, Inc. in a reverse merger transaction.

Serapha Bio, Inc. has entered into a definitive merger agreement to acquire Boundless Bio, Inc. in a reverse merger transaction. This deal will result in Serapha equity holders owning approximately 96.31% of the combined company, with Boundless Bio equity holders retaining 3.69%.

Tone
Positive 67/100
Event
Deals and strategy
Published
26 Jun 2026 22:40
Source
www.marketscreener.com
marketscreener.com Direct company coverage

BOLD Stock Alert: Halper Sadeh LLC is Investigating Whether Boundless Bio, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the proposed merger of Boundless Bio, Inc. (NASDAQ: BOLD) with Serapha Bio, Inc. The firm is examining whether Boundless Bio shareholders are receiving a fair price, as they are expected to own only about 3.7% of the

Tone
Negative 36/100
Event
Deals and strategy
Published
26 Jun 2026 22:40
Source
marketscreener.com
TradingView Direct company coverage

Boundless Bio Inc. Actuals & Estimates (NASDAQ:BOLD)

This article provides an overview of Boundless Bio, Inc. (NASDAQ: BOLD), detailing its financial actuals and estimates, stock performance, and analyst forecasts. It covers the current stock price, historical highs and lows, market capitalization, upcoming earnings reports, and te

Tone
Positive 69/100
Event
Earnings
Published
26 Jun 2026 20:40
Source
TradingView